Table 3:
Observed cumulative incidence of each composite event type at 30 days and 1 year, by number of uncontrolled risk factors.
| Variable | None | 1 | 2 or more | p-value |
|---|---|---|---|---|
| N | 260 | 321 | 200 | |
| Mortality | ||||
| 30 days | * | * | * | .43 |
| 1 year | 40 (15.5%) | 44 (14.2%) | 20 (10.2%) | .23 |
| All-cause hospitalization | ||||
| 30 days | 34 (13.1%) | 39 (12.2%) | 31 (15.6%) | .53 |
| 1 year | 119 (46.0%) | 145 (46.3%) | 94 (47.6%) | .96 |
| MAVE: Major Adverse Cardiac or Limb Events | ||||
| 30 days | 15 (5.8%) | 37 (11.5%) | 27 (13.6%) | .01 |
| 1 year | 81 (31.4%) | 107 (34.2%) | 80 (40.5%) | .08 |
| MACE: Major Adverse Cardiac Events | ||||
| 30 days | * | * | * | .51 |
| 1 year | 30 (11.6%) | 32 (10.3%) | 33 (16.8%) | .09 |
| Myocardial Infarction | ||||
| 1 year | * | 13 (4.2%) | 14 (7.1%) | .08 |
| Stroke | ||||
| 1 year | * | 20 (6.4%) | 21 (10.7%) | .21 |
| MALE: Major Adverse Limb Events | ||||
| 30 days | * | 26 (8.1%) | 19 (9.5%) | .006 |
| 1 year | 36 (13.9%) | 58 (18.4%) | 50 (25.2%) | .007 |
| Revascularization | ||||
| 1 year | 24 (9.3%) | 44 (13.9%) | 38 (19.2%) | .008 |
| Amputation | ||||
| 1 year | 18 (7.0%) | 24 (7.6%) | 17 (8.6%) | .79 |
*
Cell size of less than 11 removed in accordance with CMS cell suppression policy
MACE: major adverse cardiac events (mortality + myocardial infarction + stroke); MALE: major adverse limb events (revascularization + amputation); MAVE: major adverse vascular events (mortality + myocardial infarction + stroke + revascularization + amputation)